129 related articles for article (PubMed ID: 33322783)
1. New Multifunctional Agents Based on Conjugates of 4-Amino-2,3-polymethylenequinoline and Butylated Hydroxytoluene for Alzheimer's Disease Treatment.
Makhaeva GF; Kovaleva NV; Rudakova EV; Boltneva NP; Lushchekina SV; Faingold II; Poletaeva DA; Soldatova YV; Kotelnikova RA; Serkov IV; Ustinov AK; Proshin AN; Radchenko EV; Palyulin VA; Richardson RJ
Molecules; 2020 Dec; 25(24):. PubMed ID: 33322783
[TBL] [Abstract][Full Text] [Related]
2. Insight into antioxidant-like activity and computational exploration of identified bioactive compounds in Talinum triangulare (Jacq.) aqueous extract as potential cholinesterase inhibitors.
Afolabi OB; Olasehinde OR; Owolabi OV; Jaiyesimi KF; Adewumi FD; Idowu OT; Mabayoje SO; Obajuluwa AO; Akpor OB
BMC Complement Med Ther; 2024 Mar; 24(1):134. PubMed ID: 38539199
[TBL] [Abstract][Full Text] [Related]
3. Conjugates of amiridine and thiouracil derivatives as effective inhibitors of butyrylcholinesterase with the potential to block β-amyloid aggregation.
Khudina OG; Grishchenko MV; Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Shchegolkov EV; Borisevich SS; Burgart YV; Saloutin VI; Charushin VN
Arch Pharm (Weinheim); 2024 Feb; 357(2):e2300447. PubMed ID: 38072670
[TBL] [Abstract][Full Text] [Related]
4. Rivastigmine-Bambuterol Hybrids as Selective Butyrylcholinesterase Inhibitors.
Wu J; Tan Z; Pistolozzi M; Tan W
Molecules; 2023 Dec; 29(1):. PubMed ID: 38202655
[TBL] [Abstract][Full Text] [Related]
5. Exploring Medicinal Herbs' Therapeutic Potential and Molecular Docking Analysis for Compounds as Potential Inhibitors of Human Acetylcholinesterase in Alzheimer's Disease Treatment.
Farihi A; Bouhrim M; Chigr F; Elbouzidi A; Bencheikh N; Zrouri H; Nasr FA; Parvez MK; Alahdab A; Ahami AOT
Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893530
[No Abstract] [Full Text] [Related]
6. Amino-7,8-dihydro-4H-chromenone derivatives as potential inhibitors of acetylcholinesterase and butyrylcholinesterase for Alzheimer's disease management; in vitro and in silico study.
Asadipour A; Pourshojaei Y; Mansouri M; Mahdavizadeh E; Irajie C; Mottaghipisheh J; Faghih-Mirzaei E; Mahdavi M; Iraji A
BMC Chem; 2024 Apr; 18(1):70. PubMed ID: 38600537
[TBL] [Abstract][Full Text] [Related]
7. Computational Methods for the Identification of Molecular Targets of Toxic Food Additives. Butylated Hydroxytoluene as a Case Study.
Tortosa V; Pietropaolo V; Brandi V; Macari G; Pasquadibisceglie A; Polticelli F
Molecules; 2020 May; 25(9):. PubMed ID: 32397407
[TBL] [Abstract][Full Text] [Related]
8. Novel benzimidazole-based pseudo-irreversible butyrylcholinesterase inhibitors with neuroprotective activity in an Alzheimer's disease mouse model.
Spatz P; Zimmermann T; Steinmüller S; Hofmann J; Maurice T; Decker M
RSC Med Chem; 2022 Aug; 13(8):944-954. PubMed ID: 36092149
[TBL] [Abstract][Full Text] [Related]
9. Quinuclidine-Based Carbamates as Potential CNS Active Compounds.
Matošević A; Radman Kastelic A; Mikelić A; Zandona A; Katalinić M; Primožič I; Bosak A; Hrenar T
Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33804719
[TBL] [Abstract][Full Text] [Related]
10. Anti-Alzheimer's Studies on β-Sitosterol Isolated from
Ayaz M; Junaid M; Ullah F; Subhan F; Sadiq A; Ali G; Ovais M; Shahid M; Ahmad A; Wadood A; El-Shazly M; Ahmad N; Ahmad S
Front Pharmacol; 2017; 8():697. PubMed ID: 29056913
[TBL] [Abstract][Full Text] [Related]
11. Characterization and in-vitro Alzheimer's properties of exopolysaccharide from Bacillus maritimus MSM1.
Selim MS; Mohamed SS; Asker MS; Ibrahim AY; El-Newary SA; El Awady ME
Sci Rep; 2023 Jul; 13(1):11399. PubMed ID: 37452077
[TBL] [Abstract][Full Text] [Related]
12. Hybridization of Curcumin Analogues with Cinnamic Acid Derivatives as Multi-Target Agents Against Alzheimer's Disease Targets.
Chainoglou E; Siskos A; Pontiki E; Hadjipavlou-Litina D
Molecules; 2020 Oct; 25(21):. PubMed ID: 33114751
[TBL] [Abstract][Full Text] [Related]
13. Boron-based hybrids as novel scaffolds for the development of drugs with neuroprotective properties.
Cacciatore I; Turkez H; Di Rienzo A; Ciulla M; Mardinoglu A; Di Stefano A
RSC Med Chem; 2021 Nov; 12(11):1944-1949. PubMed ID: 34825189
[TBL] [Abstract][Full Text] [Related]
14. Structure-Based Scaffold Repurposing toward the Discovery of Novel Cholinesterase Inhibitors.
Dighe SN; Tippana M; van Akker S; Collet TA
ACS Omega; 2020 Dec; 5(48):30971-30979. PubMed ID: 33324805
[TBL] [Abstract][Full Text] [Related]
15. Combining Experimental and Computational Methods to Produce Conjugates of Anticholinesterase and Antioxidant Pharmacophores with Linker Chemistries Affecting Biological Activities Related to Treatment of Alzheimer's Disease.
Makhaeva GF; Kovaleva NV; Rudakova EV; Boltneva NP; Lushchekina SV; Astakhova TY; Timokhina EN; Serkov IV; Proshin AN; Soldatova YV; Poletaeva DA; Faingold II; Mumyatova VA; Terentiev AA; Radchenko EV; Palyulin VA; Bachurin SO; Richardson RJ
Molecules; 2024 Jan; 29(2):. PubMed ID: 38257233
[TBL] [Abstract][Full Text] [Related]
16. Plant-Based Nutraceutical Formulation Modulates the Human Gut Microbiota and Ferulic Acid Esterase Activity During In Vitro Fermentation.
Kunnummal SP; Sori N; Khan MA; Khan M
Curr Microbiol; 2023 Nov; 81(1):3. PubMed ID: 37940729
[TBL] [Abstract][Full Text] [Related]
17. Derivatives of 9-phosphorylated acridine as butyrylcholinesterase inhibitors with antioxidant activity and the ability to inhibit β-amyloid self-aggregation: potential therapeutic agents for Alzheimer's disease.
Makhaeva GF; Kovaleva NV; Rudakova EV; Boltneva NP; Lushchekina SV; Astakhova TY; Timokhina EN; Serebryakova OG; Shchepochkin AV; Averkov MA; Utepova IA; Demina NS; Radchenko EV; Palyulin VA; Fisenko VP; Bachurin SO; Chupakhin ON; Charushin VN; Richardson RJ
Front Pharmacol; 2023; 14():1219980. PubMed ID: 37654616
[TBL] [Abstract][Full Text] [Related]
18. Conjugates of Tacrine and Salicylic Acid Derivatives as New Promising Multitarget Agents for Alzheimer's Disease.
Makhaeva GF; Kovaleva NV; Rudakova EV; Boltneva NP; Grishchenko MV; Lushchekina SV; Astakhova TY; Serebryakova OG; Timokhina EN; Zhilina EF; Shchegolkov EV; Ulitko MV; Radchenko EV; Palyulin VA; Burgart YV; Saloutin VI; Bachurin SO; Richardson RJ
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768608
[TBL] [Abstract][Full Text] [Related]
19. Powerful Potential of Polyfluoroalkyl-Containing 4-Arylhydrazinylidenepyrazol-3-ones for Pharmaceuticals.
Burgart YV; Elkina NA; Shchegolkov EV; Krasnykh OP; Makhaeva GF; Triandafilova GA; Solodnikov SY; Boltneva NP; Rudakova EV; Kovaleva NV; Serebryakova OG; Ulitko MV; Borisevich SS; Gerasimova NA; Evstigneeva NP; Kozlov SA; Korolkova YV; Minin AS; Belousova AV; Mozhaitsev ES; Klabukov AM; Saloutin VI
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615256
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
